| dc.contributor.author | Coles, CE | |
| dc.contributor.author | Haviland, JS | |
| dc.contributor.author | Kirby, AM | |
| dc.date.accessioned | 2020-09-30T10:24:45Z | |
| dc.date.issued | 2020-12-01 | |
| dc.identifier.citation | The Lancet. Oncology, 2020, 21 (12), pp. 1541 - 1543 | |
| dc.identifier.issn | 1470-2045 | |
| dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4087 | |
| dc.identifier.eissn | 1474-5488 | |
| dc.identifier.doi | 10.1016/s1470-2045(20)30551-9 | |
| dc.format | Print-Electronic | |
| dc.format.extent | 1541 - 1543 | |
| dc.language | eng | |
| dc.language.iso | eng | |
| dc.publisher | ELSEVIER SCIENCE INC | |
| dc.subject | Lymph Nodes | |
| dc.subject | Humans | |
| dc.subject | Breast Neoplasms | |
| dc.subject | Sentinel Lymph Node Biopsy | |
| dc.title | Internal mammary node irradiation in breast cancer: does benefit outweigh risk? | |
| dc.type | Journal Article | |
| dcterms.dateAccepted | 2020-09-10 | |
| rioxxterms.versionofrecord | 10.1016/s1470-2045(20)30551-9 | |
| rioxxterms.licenseref.startdate | 2020-12 | |
| rioxxterms.type | Journal Article/Review | |
| dc.relation.isPartOf | The Lancet. Oncology | |
| pubs.issue | 12 | |
| pubs.notes | Not known | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Breast Cancer Radiotherapy | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Breast Cancer Radiotherapy/Breast Cancer Radiotherapy (hon.) | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Breast Cancer Radiotherapy | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Breast Cancer Radiotherapy/Breast Cancer Radiotherapy (hon.) | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.publication-status | Published | |
| pubs.volume | 21 | |
| pubs.embargo.terms | Not known | |
| icr.researchteam | Clinical Trials & Statistics Unit | |
| icr.researchteam | Breast Cancer Radiotherapy | |
| dc.contributor.icrauthor | Haviland, Joanne | |
